Table 3. Adverse effects.
| Outcome | Studies | N | P (95% CI) | I2 (%) |
|---|---|---|---|---|
| Infection | 3 | 16 | 0.14 (0.06–0.23) | 30.5 |
| Nausea | 5 | 14 | 0.08 (0.0–0.15) | 76.57 |
| Vomiting | 3 | 5 | 0.07 (0.01–0.14) | 0 |
| Muscle strain | 1 | 1 | 0.02 (0.0–0.09) | 0 |
| Contusion | 1 | 1 | 0.02 (0.0–0.09) | 0 |
| Gastroenteritis viral | 1 | 1 | 0.02 (0.0–0.09) | 0 |
| Abdominal pain | 1 | 5 | 0.08 (0.03–0.18) | 0 |
| Hematoma | 3 | 3 | 0.03 (0.0–0.07) | 0 |
| Hemorrhage | 1 | 3 | 0.08 (0.02–0.20) | 0 |
| Injury | 1 | 4 | 0.07 (0.02–0.16) | 0 |
| Nasopharyngitis | 1 | 3 | 0.05 (0.01–0.14) | 0 |
| Hematuria | 1 | 1 | 0.02 (0.00–0.08) | 0 |
| Fever | 4 | 27 | 0.25 (0.09–0.41) | 73.8 |
| Folliculitis | 2 | 2 | 0.02 (0.0–0.05) | 0 |
| Bilateral pneumonia | 1 | 2 | 0.09 (0.01–0.28) | 0 |
| Graves’ disease | 1 | 1 | 0.04 (0.00–0.07) | 0 |
| Diarrhea | 3 | 5 | 0.04 (0.00–0.14) | 40.26 |
| Sinusitis | 2 | 3 | 0.04 (0.00–0.22) | 0 |
| Rash | 2 | 13 | 0.05 (0.01–0.09) | 0 |
| Febrile neutropenia | 1 | 5 | 0.63 (0.24–0.91) | 0 |